PUBLISHER: Polaris Market Research | PRODUCT CODE: 1338912
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1338912
Sunitinib Malate Market Share, Size, Trends, Industry Analysis Report, By Application (Pancreatic Neuroendocrine Tumor, Kidney Cancer, Gastro-intestinal Stromal Tumor); By Region; Segment Forecast, 2023-2032
The global sunitinib malate market size is expected to reach USD 278.54 Million by 2032, according to a new study by Polaris Market Research. The report "Sunitinib Malate Market Share, Size, Trends, Industry Analysis Report, By Application (Pancreatic Neuroendocrine Tumor, Kidney Cancer, Gastrointestinal Stromal Tumor); By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The FDA's approval of sunitinib malate and other targeted cancer therapies can have a positive impact on investor confidence in the pharmaceutical industry. In the area of cancer research, 2022 saw some significant advancements. For oncology indications, the U.S. Food and Drug Administration (FDA) approved 40 drugs, 12 of which were brand-new molecules that had never been used in humans before. A recent blog post lists the FDA approvals from the previous year. This can lead to increased investment in research and development, which can lead to the discovery of new cancer treatments and further drive the growth of the market.
Globally, cancer is one of the leading causes of death and the primary cause of growth in the sunitinib market. Sunitinib Malate is used in the treatment of certain types of cancer, including renal cell carcinoma and gastrointestinal stromal tumors, and the increasing incidence of cancer worldwide is driving the demand for cancer therapies. According to the World Health Organization (WHO), cancer is a leading cause of death worldwide, with an estimated 19.3 million new cases and 10 million cancer-related deaths in 2020. The incidence of cancer is expected to continue to increase in the coming years, driven by factors such as an aging population, lifestyle changes, and environmental factors.
The increasing healthcare expenditure in developed and developing countries is expected to drive the growth of the sunitinib malate market. The rise in healthcare expenditure is due to various factors such as the aging population, rising prevalence of chronic diseases, and increasing government initiatives to improve cancer care. The database OECD Health Data 2022, updated in November 2022, states that preliminary estimates for a group of 20 countries indicate that health spending rose by about 6% on average in 2021.
The development of new and innovative cancer treatments, including targeted therapies such as sunitinib malate, is driving the growth of the market. These therapies offer improved efficacy and fewer side effects compared to traditional chemotherapy. According to the American Association for Cancer Research, early in 2022, there will be more cancer survivors in the United States than the predicted 18 million, due to developments in cancer research and treatment over the previous decades. There is still much to be done to lessen the burden of preventable cancer, despite the advancements it has achieved in the detection and treatment of the disease.
Sunitinib Malate Market Report Highlights
Pancreatic Neuroendocrine Tumor segment accounted for the higher growth rate owing to the increasing incidence of PNET.
North America is projected to experience higher growth and larger revenue share due to the high prevalence of cancer.
Europe is expected to registered with the second-largest revenue share in the study period due to the growing elderly population.
The global players include: Pfizer, Top Care Pharmacy, J&K Scientific, Targetmol, Active Biotech, Astellas Pharma, AstraZeneca, Bristol Myers Squibb, Dendreon, Endo International & Ferring Pharmaceuticals.
Polaris Market Research has segmented the sunitinib malate market report based on application and region:
Sunitinib Malate, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Pancreatic Neuroendocrine Tumor
- Kidney Cancer
- Gastrointestinal Stromal Tumor
- Sunitinib Malate, Regional Outlook (Revenue - USD Million, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Sunitinib Malate Market Insights
- 4.1. Sunitinib Malate Market - Industry Snapshot
- 4.2. Sunitinib Malate Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing demand for effective cancer treatments
- 4.2.1.2. Government investment in healthcare infrastructure
- 4.2.2. Restraints and Challenges
- 4.2.2.1.
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Value Chain Analysis
- 4.6. Sunitinib Malate Industry trends
- 4.7. COVID-19 Impact Analysis
5. Global Sunitinib Malate Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 5.3. Pancreatic Neuroendocrine Tumor
- 5.3.1. Global Sunitinib Malate Market, by Pancreatic Neuroendocrine Tumor, by Region, 2019-2032 (USD Million)
- 5.4. Kidney Cancer
- 5.4.1. Global Sunitinib Malate Market, by Kidney Cancer, by Region, 2019-2032 (USD Million)
- 5.5. Gastrointestinal Stromal Tumor
- 5.5.1. Global Sunitinib Malate Market, by Gastrointestinal Stromal Tumor, by Region, 2019-2032 (USD Million)
6. Global Sunitinib Malate Market, by Geography
- 6.1. Key findings
- 6.2. Introduction
- 6.2.1. Sunitinib Malate Market Assessment, By Geography, 2019-2032 (USD Million)
- 6.3. Sunitinib Malate Market - North America
- 6.3.1. North America: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.3.2. Sunitinib Malate Market - U.S.
- 6.3.2.1. U.S.: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.3.3. Sunitinib Malate Market - Canada
- 6.3.3.1. Canada: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.4. Sunitinib Malate Market - Europe
- 6.4.1. Europe: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.4.2. Sunitinib Malate Market - UK
- 6.4.2.1. UK: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.4.3. Sunitinib Malate Market - France
- 6.4.3.1. France: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.4.4. Sunitinib Malate Market - Germany
- 6.4.4.1. Germany: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.4.5. Sunitinib Malate Market - Italy
- 6.4.5.1. Italy: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.4.6. Sunitinib Malate Market - Spain
- 6.4.6.1. Spain: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.4.7. Sunitinib Malate Market - Netherlands
- 6.4.7.1. Netherlands: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.4.8. Sunitinib Malate Market - Austria
- 6.4.8.1. Austria: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.5. Sunitinib Malate Market - Asia Pacific
- 6.5.1. Asia Pacific: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.5.2. Sunitinib Malate Market - China
- 6.5.2.1. China: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.5.3. Sunitinib Malate Market - India
- 6.5.3.1. India: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.5.4. Sunitinib Malate Market - Malaysia
- 6.5.4.1. Malaysia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.5.5. Sunitinib Malate Market - Japan
- 6.5.5.1. Japan: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.5.6. Sunitinib Malate Market - Indonesia
- 6.5.6.1. Indonesia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.5.7. Sunitinib Malate Market - South Korea
- 6.5.7.1. South Korea: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.6. Sunitinib Malate Market - Middle East & Africa
- 6.6.1. Middle East & Africa: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.6.2. Sunitinib Malate Market - Saudi Arabia
- 6.6.2.1. Saudi Arabia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.6.3. Sunitinib Malate Market - UAE
- 6.6.3.1. UAE: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.6.4. Sunitinib Malate Market - Israel
- 6.6.4.1. Israel: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.6.5. Sunitinib Malate Market - South Africa
- 6.6.5.1. South Africa: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.7. Sunitinib Malate Market - Latin America
- 6.7.1. Latin America: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.7.2. Sunitinib Malate Market - Mexico
- 6.7.2.1. Mexico: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.7.3. Sunitinib Malate Market - Brazil
- 6.7.3.1. Brazil: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- 6.7.4. Sunitinib Malate Market - Argentina
- 6.7.4.1. Argentina: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
7. Competitive Landscape
- 7.1. Expansion and Acquisition Analysis
- 7.1.1. Expansion
- 7.1.2. Acquisitions
- 7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
- 8.1. Pfizer
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Recent Development
- 8.2. Top Care Pharmacy
- 8.2.1. Company Overview
- 8.2.2. Financial Performance
- 8.2.3. Product Benchmarking
- 8.2.4. Recent Development
- 8.3. J&K Scientific
- 8.3.1. Company Overview
- 8.3.2. Financial Performance
- 8.3.3. Product Benchmarking
- 8.3.4. Recent Development
- 8.4. Targetmol
- 8.4.1. Company Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.4. Recent Development
- 8.5. Active Biotech
- 8.5.1. Company Overview
- 8.5.2. Financial Performance
- 8.5.3. Product Benchmarking
- 8.5.4. Recent Development
- 8.6. Astellas Pharma
- 8.6.1. Company Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.4. Recent Development
- 8.7. AstraZeneca
- 8.7.1. Company Overview
- 8.7.2. Financial Performance
- 8.7.3. Product Benchmarking
- 8.7.4. Recent Development
- 8.8. Bristol Myers Squibb
- 8.8.1. Company Overview
- 8.8.2. Financial Performance
- 8.8.3. Product Benchmarking
- 8.8.4. Recent Development
- 8.9. Dendreon
- 8.9.1. Company Overview
- 8.9.2. Financial Performance
- 8.9.3. Product Benchmarking
- 8.9.4. Recent Development
- 8.10. Endo International
- 8.10.1. Company Overview
- 8.10.2. Financial Performance
- 8.10.3. Product Benchmarking
- 8.10.4. Recent Development
- 8.11. Ferring Pharmaceuticals
- 8.11.1. Company Overview
- 8.11.2. Financial Performance
- 8.11.3. Product Benchmarking
- 8.11.4. Recent Development
List of Tables
- Table 1 Global Smart Railway Market, by Application, 2019-2032 (USD Million)
- Table 2 Sunitinib Malate Market Assessment, By Geography, 2019-2032 (USD Million)
- Table 3 North America: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 4 U.S.: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 5 Canada: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 6 Canada: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 7 Europe: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 8 Spain: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 9 Netherlands: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 10 Austria: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 11 Germany: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 12 Italy: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 13 France: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 14 Asia Pacific: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 15 China: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 16 Japan: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 17 India: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 18 Indonesia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 19 South Korea: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 20 Malaysia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 21 Latin America: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 22 Brazil: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 23 Mexico: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 24 Argentina: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 25 Middle East & Africa: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 26 South Africa: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 27 Israel: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 28 Saudi Arabia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
- Table 29 UAE: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
List of Figures
- Figure 1 Global Sunitinib Malate Market, 2019-2032 (USD Million)
- Figure 2 Integrated Ecosystem
- Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4 Market by Geography
- Figure 5 Porter's Five Forces
- Figure 6 Market by Application
- Figure 7 Global Sunitinib Malate Market, by Application, 2022 & 2032 (USD Million)
- Figure 8 Sunitinib Malate Market Assessment, By Geography, 2019-2032 (USD Million)
- Figure 9 Strategic Analysis - Sunitinib Malate Market
